Andrej Egorov
Directeur Technique/Scientifique/R&D chez Avir Green Hills Biotechnology AG
Profil
Andrej Egorov has a current job as Vice President-Research at Avir Green Hills Biotechnology AG.
Postes actifs de Andrej Egorov
| Sociétés | Poste | Début |
|---|---|---|
Avir Green Hills Biotechnology AG
 Avir Green Hills Biotechnology AG Medical SpecialtiesHealth Technology AVIR Green Hills Biotechnology is a biopharmaceutical company based in Vienna, Austria. The company uses its know-how in virology to develop and commercialize innovative products that offer cost-effective treatment for a wide range of diseases. The products under development by AVIR Green Hills Biotechnology are unique therapies against viral infectious diseases and cancer with the aim to significantly improve health and the quality of life of human beings. In exploratory research and product development, AVIR Green Hills Biotechnology is closely cooperating with national and international academic institutions and Clinics, among them include the Clinics of the Medical University Vienna, and the Institute for Medical Virology at Goethe-University Frankfurt am Main. For clinical trials, the firm collaborates with experienced and renowned institutions, such as the General Hospital Vienna. For phase III clinical trials, regulatory approval, marketing and sales it will seek strategic partnerships and cooperation's with pharmaceutical or biotechnological companies. | Directeur Technique/Scientifique/R&D | 17/09/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Avir Green Hills Biotechnology AG
Avir Green Hills Biotechnology AG Medical SpecialtiesHealth Technology AVIR Green Hills Biotechnology is a biopharmaceutical company based in Vienna, Austria. The company uses its know-how in virology to develop and commercialize innovative products that offer cost-effective treatment for a wide range of diseases. The products under development by AVIR Green Hills Biotechnology are unique therapies against viral infectious diseases and cancer with the aim to significantly improve health and the quality of life of human beings. In exploratory research and product development, AVIR Green Hills Biotechnology is closely cooperating with national and international academic institutions and Clinics, among them include the Clinics of the Medical University Vienna, and the Institute for Medical Virology at Goethe-University Frankfurt am Main. For clinical trials, the firm collaborates with experienced and renowned institutions, such as the General Hospital Vienna. For phase III clinical trials, regulatory approval, marketing and sales it will seek strategic partnerships and cooperation's with pharmaceutical or biotechnological companies. | Health Technology |
